Results 101 to 110 of about 11,409 (147)

Clinical biochemistry profile of American Quarter Horse broodmares fed Tifton-85 (Cynodon spp.) hay and haylage

open access: yesPesquisa Veterinária Brasileira
: The conservation of haylage (a pre-dried feed) can be challenging, since there is an increased risk of mould growth, which can contaminate this foodstuff with mycotoxins.
Taciano C. Guimarães   +7 more
doaj   +1 more source

Bronchial Responsiveness Is Related to Increased Exhaled NO (FENO) in Non-Smokers and Decreased FENO in Smokers [PDF]

open access: yes, 2012
Rationale Both atopy and smoking are known to be associated with increased bronchial responsiveness. Fraction of nitric oxide (NO) in the exhaled air (FENO), a marker of airways inflammation, is decreased by smoking and increased by atopy.
Torén, Kjell   +31 more
core   +1 more source

The Role of Innate Lymphoid Cells in Autoimmune, Allergic and Infectious Diseases: A Systematic Review

open access: yesImmunology, EarlyView.
This systematic review establishes disease‐specific dysregulations of human innate lymphoid cells (ILCs), demonstrating that an ILC1/ILC3 imbalance compromises mucosal barriers in inflammatory bowel disease, while activated ILC2s drive allergic airway inflammation.
Luan F. Lückmann   +7 more
wiley   +1 more source

% difference of FENO after MDP challenge by baseline FENO, asthma, atopy and BHR severity.

open access: yes, 2013
Abbreviations: FENO, fractional exhaled nitric oxide; MDP, mannitol dry powder; BHR, bronchial hyperresponsiveness; SPT, skin prick test. Baseline FENO defined as tertiles (low levels: 30 ppb).
Daniel Trachsel (287960)   +5 more
core   +1 more source

From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1255-1265, November 2026.
Digital patients and in silico clinical trials offer new opportunities to advance pharmacological research, clinical development, and regulatory decision‐making by enabling the simulation of treatment effects prior to testing in patients. Among the most promising of these opportunities is the combined use of quantitative systems pharmacology (QSP) and ...
Thomas Klabunde   +3 more
wiley   +1 more source

Is It Safe to Reduce Inhaled Corticosteroid Dose in Severe Asthma Patients Receiving Biologic Therapy?

open access: yesClinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Background Biologic therapies can control severe asthma and may modify its natural history beyond symptom control. However, step‐down is not standardized, and its safety has not been clearly established. Methods This single‐center retrospective cohort study reviewed adults with severe asthma on biologics (January 2019–May 2024).
Nagihan Orhan Özer   +4 more
wiley   +1 more source

Assessing the suitability of Fractional Exhaled Nitric Oxide (FENO) cut-off ranges for aboriginal and/or Torres Strait Islander children and young adults

open access: yes, 2018
Introduction/Aim Fractional exhaled nitric oxide (FeNO) is used as a non‐invasive measure of eosinophilic airway inflammation. It is unknown how appropriate the recommended FeNO cut‐off ranges are for Aboriginal and/or Torres Strait Islander patients ...
Chang, A   +4 more
core   +1 more source

Efficacy of Biologics in Aspirin Exacerbated Respiratory Disease

open access: yesClinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Background Aspirin‐exacerbated respiratory disease (AERD), also termed nonsteroidal anti‐inflammatory drug exacerbated respiratory disease (NERD), is characterized by asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to cyclooxygenase‐1 inhibitors, frequently resulting in severe, treatment‐refractory airway disease ...
Jennifer K. Priessnitz   +4 more
wiley   +1 more source

Relationship Between Bronchodilator Reversibility and Spirometry Response to Dupilumab in Type 2 High Uncontrolled Severe Asthma

open access: yes
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 253-255, March 2025.
Robert Greig   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy